Product Information

GENTAMICIN 80 MG/2 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.2576 per ML under NDC 63323001002. Its NADAC has been published 463 times since Nov 28, 2013.

FDA first approved this application on Aug 4, 1983. Its Orange Book therapeutic-equivalence code is AP.

GENTAMICIN 80 MG/2 ML VIAL

GENTAMICIN SULFATE
$1.2576per ML

Strength

40 mg/mL

NDC

63323001002

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

10/21/2026

Active Ingredients

GENTAMICIN SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA062366

FDA Approved

8/4/1983

TE Code

AP

On Market Since

8/10/2000

Pharmacological Classes

Price Statistics

The NADAC for GENTAMICIN 80 MG/2 ML VIAL has been published 463 times since Nov 28, 2013, and over the history we have for it it has risen 41.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2576 per ML
All-time high$1.8675 (Nov 13, 2024)
All-time low$0.5032 (Aug 17, 2016)
52-week high$1.6728
52-week low$1.2576
Median price$0.9293
Average price$1.0442
Largest weekly change+121.9% (Feb 19, 2020)
Weeks tracked463
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-3.5%

3M

-7.4%

6M

-9.4%

1Y

-24.4%

3Y

+82.0%

5Y

+82.0%

All

+41.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GENTAMICIN 80 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for GENTAMICIN 80 MG/2 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $1.2576 per ML (NDC 63323001002), effective Nov 11, 2026.

How has the price of GENTAMICIN 80 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for GENTAMICIN 80 MG/2 ML VIAL has risen 41.7%. It has been tracked across 463 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GENTAMICIN 80 MG/2 ML VIAL?

Since Nov 28, 2013, the NADAC for GENTAMICIN 80 MG/2 ML VIAL has ranged from a low of $0.5032 (Aug 17, 2016) to a high of $1.8675 (Nov 13, 2024), with a median of $0.9293 per ML.

Are there cheaper alternatives to GENTAMICIN 80 MG/2 ML VIAL?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GENTAMICIN 40 MG/ML VIAL, is $0.9335 per ML — about 26% below GENTAMICIN 80 MG/2 ML VIAL.

Who manufactures GENTAMICIN 80 MG/2 ML VIAL?

GENTAMICIN 80 MG/2 ML VIAL (NDC 63323001002) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.